Endocan and Asymmetric Dimethylarginine as an Etiological Indicator in the Maternal and Umbilical Cord Serum in Pre-Eclampsia


İNANDIKLIOĞLU N. , BAŞER E. , AYDOĞAN KIRMIZI D.

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, vol.59, no.4, pp.308-312, 2021 (Journal Indexed in ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 59 Issue: 4
  • Publication Date: 2021
  • Doi Number: 10.4274/haseki.galenos.2021.7101
  • Title of Journal : HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI
  • Page Numbers: pp.308-312
  • Keywords: N, N-dimethylarginine, preeclampsia, pregnancy, proteoglycans, umbilical cord, NITRIC-OXIDE SYNTHESIS, PLASMA-CONCENTRATIONS, ENDOGENOUS INHIBITOR, NORMAL-PREGNANCY, ADMA, SEVERITY, SYNTHASE, WOMEN

Abstract

Aim: Preeclampsia is a pregnancy-specific disease of unknown etiology. This study was planned to determine the place of asymmetric dimethylarginine (N, N-dimethylarginine, ADMA) and endothelial cell specific molecule-1 (ESM1, endocan) levels in etiology. The aim of this study was to determine ADMA and endocan levels in maternal and fetal umbilical cord serum of patients with preeclampsia and to evaluate them with clinical data.